Wells Fargo & Company Aytu Biopharma, Inc Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.15 - $4.0 $2 - $76	19 Added 0.65%	2,933 $0
Q3 2022 Nov 14, 2022	BUY	$0.19 - $3.8 $37 - $741	195 Added 7.17%	2,914 $0
Q2 2022 Aug 12, 2022	BUY	$0.46 - $1.08 $3 - $7	7 Added 0.26%	2,719 $2,000
Q1 2022 May 16, 2022	SELL	$1.08 - $1.55 $69 - $99	-64 Reduced 2.31%	2,712 $3,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $454 - $994	-337 Reduced 10.83%	2,776 $4,000
Q3 2021 Nov 15, 2021	SELL	$2.78 - $5.12 $403 - $742	-145 Reduced 4.45%	3,113 $9,000
Q2 2021 Aug 16, 2021	SELL	$4.73 - $7.56 $37,362 - $59,716	-7,899 Reduced 70.8%	3,258 $17,000
Q1 2021 May 13, 2021	SELL	$6.23 - $9.88 $43,996 - $69,772	-7,062 Reduced 38.76%	11,157 $85,000
Q4 2020 Feb 09, 2021	BUY	$5.98 - $13.5 $108,949 - $245,956	18,219 New	18,219 $108,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $88.7M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.